Pinokalant

CAS : 149759-26-2

Ref. TM-T70540

Informations sur le produit

• Nom: Pinokalant
• Synonymes: LOE-908, 1-Isoquinolineacetamide, 3,4-dihydro-6,7-dimethoxy-α-phenyl-N,N-bis[2-(2,3,4-trimethoxyphenyl)ethyl]-, 2-(6,7-dimethoxy-3,4-dihydroisoquinolin-1-yl)-2-phenyl-N,N-bis[2-(2,3,4-trimethoxyphenyl)ethyl]acetamide, 3,4-Dihydro-6,7-dimethoxy-α-phenyl-N,N-bis[2-(2,3,4-trimethoxyphenyl)ethyl]-1-isoquinolineacetamide, Loe 908
• CAS: 149759-26-2

Description

Pinokalant (LOE-908) is a novel non-selective cation channel inhibitor.Pinokalant significantly reduces cortical infarct volume in in vivo experiments, improves the metabolic and electrophysiological status of the ischemic penumbra region, and reduces the size of the lesion on magnetic resonance images in the acute phase after middle cerebral artery occlusion in rats.Pinokalant is a potential SARS-CoV-2 protease inhibitor for the study of stroke.

• Marque: Targetmol

Propriétés chimiques

• Masse moléculaire: 712.83
• Formule: C₄₁H₄₈N₂O₉
• Degré de pureté: 99.09%
• Couleur/Forme: Solid